Rethinking Glaucoma Management Heru’s Advancements Of Visual Field Testing For Glaucoma

Summary

Glaucoma is a progressive disease that leads to optic disc cupping and visual field loss due to retinal ganglion cell damage, and represents the most common cause of irreversible blindness worldwide. As of 2020, about 80 million people globally were living with this chronic condition. In the United States alone more than 3 million people are living with glaucoma, 2.7 of whom — aged 40 and over — are affected by its most common form, primary open angle glaucoma. Unfortunately, it is estimated that half of glaucoma patients remain undiagnosed.

Lee Kuczewski

Recent Posts

IS IT AMD…OR NOT?
Tools to Help You Determine Whether Drusen Indicates AMD

By Greg Caldwell, OD, FAAO There are times in the life of every practitioner when making a diagnosis can be…

2 years ago

Heru Wins Prestigious CES Innovation Award for 2nd Consecutive Year with Expanded, Multimodal Platform

Heru Wins Prestigious CES Innovation Award for 2nd Consecutive Year with Expanded, Multimodal Platform MIAMI, FL (November 17, 2022) — Today,…

2 years ago

Heru Continues to Revolutionize Vision Care, Surpassing Clinical Milestone of 100,000 Eyes Examined

Heru Continues to Revolutionize Vision Care, Surpassing Clinical Milestone of 100,000 Eyes Examined MIAMI--November 14, 2022, Heru Inc. announced that…

2 years ago

Shine a Spotlight on AMD: 5 Reasons to Screen Your Patients

Shine a Spotlight on AMD: 5 Reasons to Screen Your Patients by Milan Lockhart, OD As our patient's age, their eyes…

2 years ago

Heru Makes Appointments to Its Executive Leadership Team

Miami, FL (October 31, 2022) – Today, Heru announced several key executive appointments across its leadership team and board of…

2 years ago